Premier Research Group Limited, the international pharmaceutical services company, has submitted an Investigational New Drug Application which represents the 50th IND under management. The milestone IND was submitted to the FDA's Division of Anaesthesia, Analgesia and Rheumatology Products (DAARP), and is intended to support the clinical development of a novel formulation of a non-steroidal anti-inflammatory drug for the treatment of pain.
The details can be read here.
No comments:
Post a Comment